Cargando…
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer
Triple-negative breast cancer (TNBC) is the most difficult breast cancer subtype to treat due to the lack of targeted therapies. Cancer stem cells (CSCs) are strongly enriched in TNBC lesions and are responsible for the rapid development of chemotherapy resistance and metastasis. Ubiquitin-based epi...
Autores principales: | Prokakis, Evangelos, Jansari, Shaishavi, Boshnakovska, Angela, Wiese, Maria, Kusch, Kathrin, Kramm, Christof, Dullin, Christian, Rehling, Peter, Glatzel, Markus, Pantel, Klaus, Wikman, Harriet, Johnsen, Steven A., Gallwas, Julia, Wegwitz, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539310/ https://www.ncbi.nlm.nih.gov/pubmed/37770435 http://dx.doi.org/10.1038/s41419-023-06157-5 |
Ejemplares similares
-
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
por: Wegwitz, Florian, et al.
Publicado: (2020) -
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments
por: Mieczkowska, Iga K., et al.
Publicado: (2021) -
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer
por: Pantelaiou-Prokaki, Garyfallia, et al.
Publicado: (2022) -
The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells
por: Schneider, Deborah, et al.
Publicado: (2019) -
USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response
por: Prokakis, Evangelos, et al.
Publicado: (2021)